| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 6 |
| 1 | PREDNISONE | 6 |
| 2 | FOLIC ACID | 5 |
| 3 | METHOTREXATE | 5 |
| 4 | ACETAMINOPHEN | 2 |
| 5 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 6 | RUXOLITINIB | 2 |
| 7 | TOFACITINIB | 2 |
| 8 | ACYCLOVIR | 1 |
| 9 | ALLOPURINOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SONIDEGIB | 1 | 0.0006 |
| 1 | DUTASTERIDE | 1 | 0.0001 |
| 2 | ZIDOVUDINE | 1 | 0.0001 |
| 3 | GEMFIBROZIL | 1 | 0.0001 |
| 4 | CLOTRIMAZOLE TOPICAL | 1 | 0.0001 |
| 5 | CLOTRIMAZOLE | 1 | 0.0001 |
| 6 | REMDESIVIR | 1 | 0.0001 |
| 7 | POSACONAZOLE | 1 | 0.0001 |
| 8 | VALGANCICLOVIR | 1 | 0.0001 |
| 9 | HYDROXYUREA | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 6 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 5 |
| 2 | Vitamin B12 [EPC] | 5 |
| 3 | Vitamin C [EPC] | 5 |
| 4 | Vitamin D [EPC] | 5 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 2 |
| 6 | Expectorant [EPC] | 2 |
| 7 | Janus Kinase Inhibitor [EPC] | 2 |
| 8 | Kinase Inhibitor [EPC] | 2 |
| 9 | Adenosine Receptor Agonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Vitamin D [EPC] | 5 | 0.0000 |